Concepedia

Author

Masaharu Fukami

Daiichi-Sankyo (Japan)

Also Known As

MASAHARU FUKAMI, Masaharu FUKAMI, Masaharu Fukami

17

Publications

522

Citations

8

H-Index

26

Concepts

All Affiliations

Daiichi-Sankyo (Japan)Kobe UniversityBiomedical Research Laboratories (United States)Daiichi Sankyo (Germany)
MF

About

Masaharu Fukami is an author at Daiichi-Sankyo (Japan) specializing in physiology, medicine, and health sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

369

2

Health Sciences

5

5

311

3

Biochemistry

3

3

168

4

Public Health

1

1

58

5

Endocrinology

1

1

94

Masaharu Fukami

×

8

Publications

504

Citations

8

H-Index

YearCitations

Reduction of Serum Cholesterol Levels Alters Lesional Composition of Atherosclerotic Plaques

Masashi Shiomi, Takashi Ito, Toyohiro Tsukada,

Arteriosclerosis Thrombosis and Vascular Biology

1995

128

Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in - mice

Toshihiko Fujiwara, Mikiyo Wada, Kuniaki Fukuda,

Metabolism

1991

116

The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats

Tomoyuki Fujioka, Futoshi Nara, Yoshio Tsujita,

Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism

1995

94

Suppression of established atherosclerosis and xanthomas in mature WHHL rabbits by keeping their serum cholesterol levels extremely low

Masashi Shiomi, Takashi Ito, Yoshio Watanabe,

Atherosclerosis

1990

58

Effects of HMG-CoA reductase inhibitors on skeletal muscles of rabbits

Masaharu Fukami, Naoyuki Maeda, Junichiroh Fukushige,

Research in Experimental Medicine

1993

58

Beneficial renal effects of CS-905, a novel dihydropyridine calcium blocker, in SHR.

Kiyoshi Oizumi, Hiroshi Nishino, Masaaki Miyamoto,

The Japanese Journal of Pharmacology

1989

19

Effects of Pravastatin Sodium Alone and in Combination with Cholestyramine on Hepatic, Intestinal and Adrenal Low Density Lipoprotein Receptors in Homozygous Watanabe Heritable Hyperlipidemic Rabbits

Masao Kuroda, Akiyo Matsumoto, Hiroshige Itakura,

The Japanese Journal of Pharmacology

1992

16

Improvement of bioavailability of poorly absorbed drugs. III. Oral acute toxicity and local irritation of medium chain glyceride.

Minoru Sekine, Emiko Maeda, Kunihiro Sasahara,

Journal of Pharmacobio-Dynamics

1985

15

Page 1